Sonnet BioTherapeutics Holdings, Inc. (SONN) Stock on a Bullish Journey, Here’s the Cause

Sonnet BioTherapeutics Holdings, Inc. (SONN), a clinical-stage biotechnology company focused on oncology, has gained an increase of 18.43 percentage points in the pre-market trading session. Consequently, the stock was trading at $0.61 when last checked. During Wednesday’s regular trading session, the stock rocketed by 86.73% to close the day at $0.52. The tremendous increase followed […]

News IMC
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.